Lupin Limited has secured approval for its abbreviated new drug application (ANDA) for Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg from the United States Food and Drug Administration (FDA). The approved product of the Indian pharma company is a generic equivalent of Pfizer’s Toviaz Extended-Release Tablets, 4 mg and 8 mg, which is […]
Dr. Reddy’s Laboratories has launched Dr. Reddy’s Fesoterodine Fumarate Extended-Release Tablets in the US market following the approval of the US Food and Drug Administration (FDA). The product is generic of Toviaz (fesoterodine fumarate) Extended-Release Tablets of Pfizer, an antimuscarinic drug used for the treatment of certain bladder problems. According to IQVIA, the Toviaz brand […]
Alembic Pharmaceuticals said that it has secured tentative approval from the US Food & Drug Administration (FDA) for its abbreviated new drug application (ANDA) for its generic drug product Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg. The tentatively approved product is the generic of Pfizer’s Toviaz Extended-Release Tablets, 4 mg and 8 mg. […]